You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relapsing Multiple Sclerosis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsing Multiple Sclerosis, Multiple Sclerosis Trial (Placebo, Pirtobrutinib)

Not yet recruiting
  • Relapsing Multiple Sclerosis
  • Multiple Sclerosis
  • (no location specified)
Oct 24, 2023

Ocrelizumab and Ofatumumab Administration in Relapsing Multiple

Completed
  • Relapsing Forms of Multiple Sclerosis
  • Lutherville, Maryland
  • +1 more
Oct 19, 2022

Concentration of BRIUMVI™ (Ublituximab) in Breast Milk

Not yet recruiting
  • Relapsing Multiple Sclerosis
  • No intervention
  • (no location specified)
Nov 16, 2023

Ofatumumab in Portuguese Multiple Sclerosis Patients

Not yet recruiting
  • Relapsing Multiple Sclerosis
  • Ofatumumab
  • (no location specified)
Mar 30, 2023

Relapsing Multiple Sclerosis Trial in Beijing (Mitoxantrone Hydrochloride Liposome Injection)

Not yet recruiting
  • Relapsing Multiple Sclerosis
  • Mitoxantrone Hydrochloride Liposome Injection
  • Beijing, Beijing, China
    Xuanwu Hospital Capital Medical University
Aug 9, 2022

Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive Trial in Tokyo (OCH-NCNP1, Placebo)

Active, not recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Multiple Sclerosis, Secondary Progressive
  • Tokyo, Japan
    National Center of Neurology and Psychiatry
Sep 28, 2022

Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Demyelinating Autoimmune Diseases, CNS Trial in Amsterdam

Recruiting
  • Multiple Sclerosis
  • +5 more
  • Amsterdam, Netherlands
    Amsterdam UMC, location VUmc
Apr 17, 2023

COVID-19 Vaccine in Multiple Sclerosis Participants Treated With

Completed
  • Relapsing Multiple Sclerosis
  • Ofatumumab
  • Covid-19 vaccine
  • Phoenix, Arizona
  • +4 more
Jan 23, 2023

Multiple Sclerosis Trial in Germany (Ofatumumab)

Active, not recruiting
  • Multiple Sclerosis
  • Berlin, Germany
  • +5 more
Jan 13, 2023

Multiple Sclerosis Trial in United States (Ocrelizumab, Placebo for Ocrelizumab)

Recruiting
  • Multiple Sclerosis
  • New Haven, Connecticut
  • +9 more
Jan 17, 2023

Relapsing Multiple Sclerosis Trial in Worldwide (fenebrutinib, )

Recruiting
  • Relapsing Multiple Sclerosis
  • Fullerton, California
  • +16 more
Jan 24, 2023

Early Versus Late Ofatumumab Use in Austrian RMS-Patients Over 2

Not yet recruiting
  • Relapsing Multiple Sclerosis
  • Ofatumumab
  • (no location specified)
Mar 17, 2023

Relapsing Remitting Multiple Sclerosis Trial in Portland (3 mg Melatonin, 5 mg Melatonin)

Active, not recruiting
  • Relapsing Remitting Multiple Sclerosis
  • 3 mg Melatonin
  • 5 mg Melatonin
  • Portland, Oregon
    Providence MS Center
May 5, 2022

Multiple Sclerosis Trial (Fecal Microbial Transplants)

Not yet recruiting
  • Multiple Sclerosis
  • Fecal Microbial Transplants
  • (no location specified)
Oct 24, 2022

Relapsing Remitting Multiple Sclerosis Trial (PIPE-307 Dose A, PIPE-307 Dose B, Placebo)

Not yet recruiting
  • Relapsing Remitting Multiple Sclerosis
  • PIPE-307 Dose A
  • +2 more
  • (no location specified)
Oct 9, 2023

RMS Patients on Ofatumumab or Ocrelizumab inReal-World Setting

Recruiting
  • Relapsing Multiple Sclerosis
  • Ofatumumab
  • Ocrelizumab
  • Dubai, United Arab Emirates
    Novartis Investigative Site
Aug 8, 2022

Relapsing-remitting Multiple Sclerosis Trial (CT-P53, US-Ocrevus, EU-Ocrevus)

Not yet recruiting
  • Relapsing-remitting Multiple Sclerosis
  • CT-P53
  • +2 more
  • (no location specified)
Jun 7, 2023

Cladribine Tablets in Highly-active Relapsing Multiple Sclerosis

Recruiting
  • Relapsing-Remitting Multiple Sclerosis
    • Coventry, United Kingdom
    • +7 more
    May 20, 2022

    Multiple Sclerosis Trial in Montpellier (Magnetic Resonance Imaging, Blood withdrawal, Neuropsychological tests)

    Not yet recruiting
    • Multiple Sclerosis
    • Magnetic Resonance Imaging
    • +2 more
    • Montpellier, France
      Neurology Department, Hopital Gui de Chauliac
    Jul 18, 2023

    Multiple Sclerosis, Relapsing-Remitting Trial in Elazig (Reiki)

    Recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • Reiki
    • Elazıg, Turkey
      Firat University
    Nov 8, 2023

    Inflammatory Disease in Multiple Sclerosis

    Active, not recruiting
    • Relapsing Multiple Sclerosis
    • Multiple Sclerosis
    • Cerebrospinal and Blood Serum Semaphorin 4A Levels
    • Portland, Oregon
      Providence St. Vincent Medical Center
    May 19, 2022

    Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in United

    Recruiting
    • Relapsing Multiple Sclerosis
    • +2 more
    • Autologous Hematopoietic Stem Cell Transplantation
    • Best Available Therapy (BAT)
    • Palo Alto, California
    • +20 more
    Jan 25, 2023

    Neurodegenerative Process Within Visual Ways In Multiple

    Completed
    • Multiple Sclerosis
      • Lille, France
        Hôpital Roger Salengro, CHRU
      Sep 20, 2022

      Assess New Participant's Perspectives Beyond Clinical Efficacy

      Not yet recruiting
      • Multiple Sclerosis, Relapsing-Remitting
        • (no location specified)
        Nov 7, 2023

        Kesimpta® Treatment Effects in Relapsing Multiple Sclerosis

        Recruiting
        • Multiple Sclerosis
        • Ofatumumab
        • Bamberg, Bavaria, Germany
        • +21 more
        Jan 25, 2023